TY - JOUR
T1 - Site-to-Site Reproducibility and Spatial Resolution in MALDI–MSI of Peptides from Formalin-Fixed Paraffin-Embedded Samples
AU - Ly, Alice
AU - Longuespée, Rémi
AU - Casadonte, Rita
AU - Wandernoth, Petra
AU - Schwamborn, Kristina
AU - Bollwein, Christine
AU - Marsching, Christian
AU - Kriegsmann, Katharina
AU - Hopf, Carsten
AU - Weichert, Wilko
AU - Kriegsmann, Jörg
AU - Schirmacher, Peter
AU - Kriegsmann, Mark
AU - Deininger, Sören Oliver
N1 - Publisher Copyright:
© 2018 The Authors. Proteomics – Clinical Application published by WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.
PY - 2019/1
Y1 - 2019/1
N2 - Purpose: To facilitate the transition of MALDI–MS Imaging (MALDI–MSI) from basic science to clinical application, it is necessary to analyze formalin-fixed paraffin-embedded (FFPE) tissues. The aim is to improve in situ tryptic digestion for MALDI–MSI of FFPE samples and determine if similar results would be reproducible if obtained from different sites. Experimental Design: FFPE tissues (mouse intestine, human ovarian teratoma, tissue microarray of tumor entities sampled from three different sites) are prepared for MALDI–MSI. Samples are coated with trypsin using an automated sprayer then incubated using deliquescence to maintain a stable humid environment. After digestion, samples are sprayed with CHCA using the same spraying device and analyzed with a rapifleX MALDI Tissuetyper at 50 µm spatial resolution. Data are analyzed using flexImaging, SCiLS, and R. Results: Trypsin application and digestion are identified as sources of variation and loss of spatial resolution in the MALDI–MSI of FFPE samples. Using the described workflow, it is possible to discriminate discrete histological features in different tissues and enabled different sites to generate images of similar quality when assessed by spatial segmentation and PCA. Conclusions and Clinical Relevance: Spatial resolution and site-to-site reproducibility can be maintained by adhering to a standardized MALDI–MSI workflow.
AB - Purpose: To facilitate the transition of MALDI–MS Imaging (MALDI–MSI) from basic science to clinical application, it is necessary to analyze formalin-fixed paraffin-embedded (FFPE) tissues. The aim is to improve in situ tryptic digestion for MALDI–MSI of FFPE samples and determine if similar results would be reproducible if obtained from different sites. Experimental Design: FFPE tissues (mouse intestine, human ovarian teratoma, tissue microarray of tumor entities sampled from three different sites) are prepared for MALDI–MSI. Samples are coated with trypsin using an automated sprayer then incubated using deliquescence to maintain a stable humid environment. After digestion, samples are sprayed with CHCA using the same spraying device and analyzed with a rapifleX MALDI Tissuetyper at 50 µm spatial resolution. Data are analyzed using flexImaging, SCiLS, and R. Results: Trypsin application and digestion are identified as sources of variation and loss of spatial resolution in the MALDI–MSI of FFPE samples. Using the described workflow, it is possible to discriminate discrete histological features in different tissues and enabled different sites to generate images of similar quality when assessed by spatial segmentation and PCA. Conclusions and Clinical Relevance: Spatial resolution and site-to-site reproducibility can be maintained by adhering to a standardized MALDI–MSI workflow.
KW - MALDI
KW - formalin-fixed paraffin embedded tissue
KW - reproducibility
KW - tissue typing
KW - workflow
UR - http://www.scopus.com/inward/record.url?scp=85058846586&partnerID=8YFLogxK
U2 - 10.1002/prca.201800029
DO - 10.1002/prca.201800029
M3 - Article
C2 - 30408343
AN - SCOPUS:85058846586
SN - 1862-8346
VL - 13
JO - Proteomics - Clinical Applications
JF - Proteomics - Clinical Applications
IS - 1
M1 - 1800029
ER -